Penimeroandranoids A–D, DMOA-Derived Meroterpenoids from the Soil Fungus Penicillium sp. sb62 and Their Bioactivities
Organic Letters · 30.01.2026 · 28 (4) · 1424-1429
DOI: 10.1021/acs.orglett.5c05302 ↗Kurz gefasst
Fachartikel in der Zeitschrift Organic Letters, online erschienen am 15.01.2026. Verfasst von Jin-Ling Chang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Hubei Key Laboratory of Natural Medicinal Chemistry and Resource Evaluation, School of Pharmacy, Tongji Medical College, Huazhong University of Scien…. Hauptthemen laut MEDLINE: Penicillium, Terpenes, Glycoside Hydrolase Inhibitors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Major Research Plan.
Abstract (Originalsprache)
Four meroterpenoids derived from 3,5-dimethylorsellinic acid (DMOA), penimeroandranoids A–D ( 1 – 4 ), were isolated from the fermentation of the soil-derived fungus Penicillium sp. sb62. Their structures and absolute configurations were elucidated by HRESIMS, 1D and 2D NMR spectroscopic data, X-ray diffraction analysis, and quantum chemical calculations. Penimeroandranoid A ( 1 ) is characterized with a 6/6/6 tricyclic system with a unique 1-one-2-hydroxy-2-methyl-3-propanoatemethyl moiety. Penimeroandranoid B ( 2 ) constitutes the second 6/6/6 tricyclic meroterpenoid featuring a propyl residue. Penimeroandranoid C ( 3 ) represents the first example of a meroterpenoid harboring a 6/6/6/5 spirocyclic framework. Penimeroandranoid D ( 4 ) is a novel natural product sharing the core motif of asperterpene-type meroterpenoids but differing in the stereochemistry at C-5 and C-10. Biological evaluation revealed that compound 1 exhibits potent α-glucosidase inhibitory activity, while compounds 1 – 4 display notable anti-inflammatory and moderate immunosuppressive effects. Based on genomic analysis of Penicillium sp. sb62, plausible biosynthetic pathways for compounds 1 – 4 are proposed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Hubei Key Laboratory of Natural Medicinal Chemistry and Resource Evaluation, School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, People's Republic of China.
- Department of Pharmacy, Tongji Medical College, Wuhan Children's Hospital, Huazhong University of Science and Technology, Wuhan 430016, People's Republic of China.
- Department of Internal Medicine, Division of Cardiology, Tongji Medical College, Tongji Hospital, Huazhong University of Science and Technology, Wuhan 430030, People's Republic of China.
- Department of Anatomy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, People's Republic of China.
- School of Pharmaceutical Sciences, Hunan University of Medicine, Huaihua 418000, People's Republic of China.
ORCID-Profile: Junjun Liu, Han-Li Ruan
Förderung
- Major Research Plan
Zitieren
APA
Chang, J. L., Zhou, Y. H., Huang, Y. X., Liu, J., Huang, Z. J., Hu, J. Y., Qin, C. L., Li, W. P., Peng, H. M., Fang, J., Jin, A., & Ruan, H. L. (2026). Penimeroandranoids A–D, DMOA-Derived Meroterpenoids from the Soil Fungus Penicillium sp. sb62 and Their Bioactivities. Organic Letters, 28(4), 1424-1429. https://doi.org/10.1021/acs.orglett.5c05302
Vancouver
Chang JL, Zhou YH, Huang YX, Liu J, Huang ZJ, Hu JY, et al. Penimeroandranoids A–D, DMOA-Derived Meroterpenoids from the Soil Fungus Penicillium sp. sb62 and Their Bioactivities. Organic Letters. 2026;28(4):1424-1429. doi:10.1021/acs.orglett.5c05302
BibTeX
@article{Chang2026,
author = {Chang, Jin-Ling and Zhou, Yin-Hui and Huang, Yun-Xian and Liu, Junjun and Huang, Zi-Jian and Hu, Jia-Yun and Qin, Chun-Lun and Li, Wan-Peng and Peng, Hui-Ming and Fang, Jinbo and Jin, An and Ruan, Han-Li},
title = {Penimeroandranoids A–D, DMOA-Derived Meroterpenoids from the Soil Fungus Penicillium sp. sb62 and Their Bioactivities},
journal = {Organic Letters},
year = {2026},
volume = {28},
number = {4},
pages = {1424--1429},
doi = {10.1021/acs.orglett.5c05302}
}
EUVIMED